Search research articles
Contact Us
Filters
Showing results (181-190 of 209) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2016
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu, Monika L Burness, Rachel Martin-Trevino, et al.
BMC Medical Genomics
|
October 21, 2017
A method to reduce ancestry related germline false positives in tumor only somatic variant calling
Rebecca F Halperin, John D Carpten, Zarko Manojlovic, et al.
Cancer Research
|
June 22, 2016
Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting
Yangyang Hu, Lin Lu, Yang Xia, et al.
Cell Metabolism
|
July 5, 2018
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo, Li Shang, Michael D Brooks, et al.
Molecular Carcinogenesis
|
June 17, 2017
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells
Xiao-Fei Zhang, De-Sheng Weng, Ke Pan, et al.
Plos Genetics
|
June 12, 2012
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells
Suling Liu, Shivani H Patel, Christophe Ginestier, et al.
Molecular Cell
|
July 24, 2012
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
Hasan Korkaya, Gwang-Il Kim, April Davis, et al.
Cancer Research
|
January 9, 2016
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
Haihong Zhong, April Davis, Maria Ouzounova, et al.
Nano Letters
|
September 14, 2020
Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs
Alireza Hassani Najafabadi, Jing Zhang, Marisa E Aikins, et al.
Oncogene
|
June 22, 2022
Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer
Johanna M Buschhaus, Shrila Rajendran, Brock A Humphries, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 209) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2016
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu, Monika L Burness, Rachel Martin-Trevino, et al.
BMC Medical Genomics
|
October 21, 2017
A method to reduce ancestry related germline false positives in tumor only somatic variant calling
Rebecca F Halperin, John D Carpten, Zarko Manojlovic, et al.
Cancer Research
|
June 22, 2016
Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting
Yangyang Hu, Lin Lu, Yang Xia, et al.
Cell Metabolism
|
July 5, 2018
Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo, Li Shang, Michael D Brooks, et al.
Molecular Carcinogenesis
|
June 17, 2017
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells
Xiao-Fei Zhang, De-Sheng Weng, Ke Pan, et al.
Plos Genetics
|
June 12, 2012
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells
Suling Liu, Shivani H Patel, Christophe Ginestier, et al.
Molecular Cell
|
July 24, 2012
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
Hasan Korkaya, Gwang-Il Kim, April Davis, et al.
Cancer Research
|
January 9, 2016
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
Haihong Zhong, April Davis, Maria Ouzounova, et al.
Nano Letters
|
September 14, 2020
Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs
Alireza Hassani Najafabadi, Jing Zhang, Marisa E Aikins, et al.
Oncogene
|
June 22, 2022
Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer
Johanna M Buschhaus, Shrila Rajendran, Brock A Humphries, et al.
Page
of 21